Guardian Pharmacy Services (GRDN) Gross Profit (2023 - 2026)

Guardian Pharmacy Services has disclosed Gross Profit across 4 years of filings, most recently posting $76.3 million for Q1 2026.

• Gross Profit for Q1 2026 came in at $76.3 million, up 18.59% year-over-year; the trailing twelve-month figure through Mar 2026 was $304.7 million (up 20.13% YoY), and the FY2025 annual result was $292.7 million, up 19.78% from the prior year.
• Gross Profit came in at $76.3 million for Q1 2026 at Guardian Pharmacy Services, down from $85.5 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $85.5 million in Q4 2025 to a low of $52.2 million in Q3 2023.
• The 4-year median for Gross Profit is $64.3 million (2025), against an average of $65.5 million.
• Peak annual rise in Gross Profit reached 27.42% in 2025, while the deepest fall reached 11.19% in 2025.
• Guardian Pharmacy Services' Gross Profit stood at $54.6 million in 2023, then increased by 22.95% to $67.1 million in 2024, then rose by 27.42% to $85.5 million in 2025, then decreased by 10.75% to $76.3 million in 2026.
• The last three Gross Profit figures came in at $76.3 million (Q1 2026), $85.5 million (Q4 2025), and $74.7 million (Q3 2025), per Business Quant data.